title: [Minimal work-up for Raynaud syndrome: a consensus report. Microcirculation Working Group of the French Vascular Medicine Society].
abstract: About ten to fifteen percent of the French population suffer from Raynaud's phenomenon. Most of the time, it is considered as primary Raynaud's phenomenon, without underlying disease. The aim of this expert consensus from the "microcirculation group" for the French Society of Vascular Medicine and the French Society for Microcirculation, was to define clinical guidelines in patients consulting for Raynaud's phenomenon. The recommended minimal screening includes clinical examination, nailfold capillaroscopy and antinuclear antibodies. In particular, the aim of this screening is to identify patients with a significant risk for scleroderma, who would need a careful follow up.
authors: Service de médecine interne et vasculaire, Hôtel-Dieu, place Alexis-Ricordeau, BP 1005, 44093 Nantes cedex 01, France. marc.pistorius@chu-nantes.fr
authors: M-A
authors: MA
authors: Pistorius
authors: P-H
authors: PH
authors: Carpentier
mesh_terms: D000974:Antibodies, Antinuclear / Q000097:blood; D004198:Disease Susceptibility; D005602:France / Q000453:epidemiology; D006801:Humans; D008833:Microcirculation; D020678:Microscopic Angioscopy; D009262:Nails / Q000098:blood supply; D010808:Physical Examination; D011928:Raynaud Disease / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology / Q000382:microbiology / Q000503:physiopathology; D012595:Scleroderma, Systemic / Q000150:complications / Q000175:diagnosis / Q000453:epidemiology; D063189:Symptom Assessment
chemical_list: D000974:Antibodies, Antinuclear